Novartis Venture Fund

9 Decision Makers · 12 Verified Contacts & Email Format

📍 Basel, Basel-Stadt, SwitzerlandFinance & Banking🗓 Est. 1996👥 11–50 employees

About Novartis Venture Fund

Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.

Email Format

{first_name}.{last_name}@nvfund.com — 100.0%

sarah.smith@nvfund.com

Leadership & Decision Makers

Contact details of 9 Novartis Venture Fund decision makers

Spyros Artavanis-Tsakonas

Chairman, Option Fund

Lauren Silverman

Managing Director

Bart Dzikowski

Managing Director, Head of Transactions & Legal

Harry Kirsch

Chief Financial Officer

Michal Silverberg

Managing Director

Laura Brass

Managing Director

David Morris

Operating Partner

Hidde Ploegh

Director- Option Fund

Argeris Karabelas

Founder

Team & Specialists

Contact details of 3 Novartis Venture Fund team members

Giovanni Ferrara

  • Work email

    g**************a@nvfund.com

Martina Blank

  • Work email

    m***********k@nvfund.com

Claire Mcnulty

  • Work email

    c************y@nvfund.com

General Emails

General company emails, e.g. customer support lines

    klydon@sosei.com

    Unclassified inbox

    giovanni.ferrara@nvfund.com

    Unclassified inbox

    martina.blank@nvfund.com

    Unclassified inbox

Similar Companies like Novartis Venture Fund

Finance & Banking · New York, NY · Est. 2001 · 11–50 employees

HQ: New York, NY

PayPal Ventures

paypal.com
Finance & Banking · San Jose, CA · Est. 2023 · 11–50 employees

HQ: San Jose, CA

Finance & Banking · San Francisco, CA · Est. 2004 · 11–50 employees

HQ: San Francisco, CA

Team8

team8.vc
Cybersecurity · Tel Aviv-yafo, Tel Aviv, Israel · Est. 2014 · 101–250 employees

HQ: Tel Aviv-yafo, Tel Aviv, Israel

Sequoia Capital

sequoiacap.com
Finance & Banking · Menlo Park, California, United States · Est. 1972 · 101–250 employees

HQ: Menlo Park, California, United States

Explore similar firms in the Finance & Banking sector

Company Info

Last updated: 29/07/2025

877 280 2296

Basel, Basel-Stadt, Switzerland

Employees: 11-50
Founded Date: 1996
Number of Exits: 71
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
Phone Number: 877 280 2296
Sub-Organization of: Novartis
Last Investment Activity: Jun 25, 2024
Investments Activity: Jun 25, 2024 Apr 11, 2024 Mar 20, 2024
Early-Stage Investments: Yes

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.